Explore more publications!

Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on December 2, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Openxcell Delivers Measurable AI Results in 2025, Setting New Standards for Enterprise Transformation in 2026
Outdoor Coffee Tables in Dubai: A Practical Guide to Materials, Styles, and Climate-Ready Choices
Dubai Property Sellers Face Rising Costs as Slow Sale Timelines Persist
Cook Islands Emerges as Leading Financial Hub in New CEO Insight Report
Brunswick Exploration Announces Non-Brokered Private Placement of $1.5M
Brunswick Exploration annonce un placement privé sans courtier de 1,5 M$
Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas
Zymeworks Announces Participation in Upcoming Conferences
The Binary Holdings: The Quiet Digital Infrastructure Company Connecting National Platforms Across Asia
Carziqo Launches Global Fundraising to Expand Autonomous Ride-Hailing Fleet
MyShop Technologies Launches MaYa, Industry's First Six-Language AI Ordering Assistant for Restaurants
A Year of Gratitude and Purpose: BlueGrace Energy Looks Ahead to 2026 and Strengthens Its 2030 Climate Goals
HFS Research Opens First Middle East Office in Dubai to Meet Rising Demand for Practical, Scaled AI Transformation
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
Total Voting Rights and Notification of Transactions of a Persons Discharging Managerial Responsibilities (PDMR)
LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
Gauzy Ltd. Raises $12 Million Investment to Advance Capital Objectives and Provides Update on Board Composition
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions